Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Chabot

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Plos Pathogens|October 31, 2007
Small-molecule inhibition of HIV pre-mRNA splicing as a novel antiretroviral therapy to overcome drug resistanceNadia Bakkour, Yea-Lih Lin, Sophie Maire, et al.
Molecular Biology of the Cell|February 22, 2008
Deletion of many yeast introns reveals a minority of genes that require splicing for functionJulie Parenteau, Mathieu Durand, Steeve Véronneau, et al.
Nature Structural & Molecular Biology|June 23, 2009
Control of alternative splicing through siRNA-mediated transcriptional gene silencingMariano Alló, Valeria Buggiano, Juan P Fededa, et al.
Nature Communications|September 20, 2013
MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiationJulian P Venables, Laure Lapasset, Gilles Gadea, et al.
RNA (New York, N.Y.)|December 17, 2013
Tumor microenvironment-associated modifications of alternative splicingJean-Philippe Brosseau, Jean-François Lucier, Hanad Nwilati, et al.
Molecular and Cellular Biology|December 29, 2011
Proteins associated with the exon junction complex also control the alternative splicing of apoptotic regulatorsLaetitia Michelle, Alexandre Cloutier, Johanne Toutant, et al.
Molecular and Cellular Biology|November 15, 2012
RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissuesJulian P Venables, Jean-Philippe Brosseau, Gilles Gadea, et al.
NAR Cancer|July 28, 2021
A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cellsMuhammad Sohail, Lulzim Shkreta, Johanne Toutant, et al.
Molecular Cell|July 24, 2007
Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzymeCélia Jeronimo, Diane Forget, Annie Bouchard, et al.
Cancer Research|February 5, 2008
Multiple alternative splicing markers for ovarian cancerRoscoe Klinck, Anne Bramard, Lyna Inkel, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Plos Pathogens|October 31, 2007
Small-molecule inhibition of HIV pre-mRNA splicing as a novel antiretroviral therapy to overcome drug resistanceNadia Bakkour, Yea-Lih Lin, Sophie Maire, et al.
Molecular Biology of the Cell|February 22, 2008
Deletion of many yeast introns reveals a minority of genes that require splicing for functionJulie Parenteau, Mathieu Durand, Steeve Véronneau, et al.
Nature Structural & Molecular Biology|June 23, 2009
Control of alternative splicing through siRNA-mediated transcriptional gene silencingMariano Alló, Valeria Buggiano, Juan P Fededa, et al.
Nature Communications|September 20, 2013
MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiationJulian P Venables, Laure Lapasset, Gilles Gadea, et al.
RNA (New York, N.Y.)|December 17, 2013
Tumor microenvironment-associated modifications of alternative splicingJean-Philippe Brosseau, Jean-François Lucier, Hanad Nwilati, et al.
Molecular and Cellular Biology|December 29, 2011
Proteins associated with the exon junction complex also control the alternative splicing of apoptotic regulatorsLaetitia Michelle, Alexandre Cloutier, Johanne Toutant, et al.
Molecular and Cellular Biology|November 15, 2012
RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissuesJulian P Venables, Jean-Philippe Brosseau, Gilles Gadea, et al.
NAR Cancer|July 28, 2021
A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cellsMuhammad Sohail, Lulzim Shkreta, Johanne Toutant, et al.
Molecular Cell|July 24, 2007
Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzymeCélia Jeronimo, Diane Forget, Annie Bouchard, et al.
Cancer Research|February 5, 2008
Multiple alternative splicing markers for ovarian cancerRoscoe Klinck, Anne Bramard, Lyna Inkel, et al.
Pageof 9